About MARR

Antibiotic resistance has been called one of the world’s most pressing public health problems. The number of bacteria resistant to antibiotics has increased in the last decade. The Michigan Antibiotic Resistance Reduction (MARR) Coalition was formed in 1997 through a grant from General Motors Corporation to help reduce unnecessary antibiotic prescribing in Michigan. Since then, we have grown to include a broad coalition of local professional and community organizations, and individuals focused on the issue of unwarranted use of antibiotics in treating self-limiting respiratory ailments, like colds, flu and most coughs.

MARR Mission Statement

The Michigan Antibiotic Resistance Reduction Coalition (MARR) seeks to improve the use of antimicrobial agents in communities throughout the state of Michigan through the collaborative educational efforts of academic, government, and community partners.

The MARR Coalition strives to

Provide the infrastructure and resources for positive interventions that support the appropriate use of antibiotics and reduce antibiotic resistance in Michigan, including:

  • Educational interventions designed to change provider-prescribing habits and improve patient communication skills.
  • Consumer educational programs about appropriate antibiotic use.
  • Reduce antimicrobial resistance in the state of Michigan and share our information nationally.
  • Provide a forum for bringing together stakeholders who share the goal of antimicrobial resistance reduction.
  • Secure accurate data on the antibiotic prescribing habits of health care providers in the outpatient setting.
  • Secure accurate data on consumer use of antibiotics.

MARR Board of Directors

  • Stephen Lerner, MD, Chair
  • Elaine Bailey, PharmD, Secretary/Treasurer
  • Julie Griffith
  • Brenda Brennan, MSPH
  • Mary O’Connor Shaw
  • Carol Bugdalski-Stutrud, RPh, FaPhA
  • Marla Gorosh-Rowe, MD

Related Information